- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00991588
Clinical Outcome of Posterior Cruciate Ligament (PCL) Posterolateral Reconstruction
July 29, 2019 updated by: Sue Barber-Westin
Reconstruction of the Posterior Cruciate Ligament and Posterolateral Structures of the Knee
The purpose of this investigation is to determine the clinical outcome of surgical reconstruction of complete ruptures to the posterior cruciate ligament (PCL) and posterolateral structures of the knee joint.
The outcome will be determined with validated and rigorous knee rating systems between 2 and 10 years postoperatively.
The results will be determined by the analysis of subjective and functional factors, sports and occupational activity levels, a comprehensive physical examination, and a radiographic evaluation.
We hypothesize that the appropriately indicated procedures will effectively restore normal knee stability and function in patients with isolated or combined injuries to these structures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Because injuries to the PCL and posterolateral structures occur with less frequency than other structures in the knee joint (such as the anterior cruciate ligament and menisci), fewer studies are available to assist the surgeon and patient with appropriate decision-making regarding conservative versus surgical treatment.
The majority of patients who sustain injury to these structures are treated conservatively.
Unfortunately, several investigations describe noteworthy symptoms and functional limitations following conservative management, and a high percentage of patients develop knee osteoarthritis that can be disabling for both recreational and daily activities.
The investigators of this study have nearly three decades of experience and have extensively studied the effects of this injury in both the laboratory and clinic settings.
It is our opinion that surgical reconstruction provides significant benefit when appropriately indicated, as has been demonstrated in our previous studies.
Especially in athletic individuals, PCL and posterolateral reconstructive procedures have advanced to the point where more predictable results can be expected to restore sufficient knee function.
Studies have demonstrated, at least in the short-term, that the majority of patients with acute ligament ruptures treated with reconstruction are able to return to various levels of sports activities.12
Whether these procedures will decrease the risk of the patient developing future osteoarthritis is unknown and requires further study.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45242
- Cincinnati Sportsmedicine and Orthopaedic Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients scheduled for PCL and/or posterolateral reconstruction
Description
Inclusion Criteria:
- Complete rupture to the posterior cruciate ligament, greater than 10 mm of increased posterior tibial translation
- Rupture to the posterolateral knee structures, greater than 5 mm of increased lateral tibiofemoral joint opening, greater than 10 degrees of increased external tibial rotation
- Patient willing to comply with postoperative rehabilitation program
Exclusion Criteria:
- Patient unwilling to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
PCL, posterolateral reconstruction
All patients who are entered into study who receive a PCL and/or posterolateral knee ligament reconstruction
|
The operative procedures involve either a single- or double-strand PCL graft which is usually harvested from the patient's knee.
In cases of multiple ligament procedures, allograft tissues may be used which are obtained from tissue banks certified by the American Associate of Tissue Banks and that have passed FDA inspection.
The posterolateral structures, including the fibular collateral ligament (FCL), are reconstructed with one or two grafts, depending upon the severity of damage encountered at surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Elimination of knee giving-way
Time Frame: Minimum 2 years postoperatively
|
Minimum 2 years postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Posterior tibial translation
Time Frame: Minimum 2 years postoperative
|
Minimum 2 years postoperative
|
|
Lateral tibiofemoral joint opening
Time Frame: Minimum 2 years postoperatively
|
Minimum 2 years postoperatively
|
|
External tibial rotation
Time Frame: Minimum 2 years postoperatively
|
Minimum 2 years postoperatively
|
|
Elimination of knee pain
Time Frame: Minimum 2 years postoperatively
|
Minimum 2 years postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frank Noyes, M.D., Cincinnati Sportsmedicine Research and Education Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
October 6, 2009
First Submitted That Met QC Criteria
October 7, 2009
First Posted (Estimate)
October 8, 2009
Study Record Updates
Last Update Posted (Actual)
July 31, 2019
Last Update Submitted That Met QC Criteria
July 29, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCLPL-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.